Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
about
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerImportance of Estrogenic Signaling and Its Mediated Receptors in Prostate CancerFatty acids derived from royal jelly are modulators of estrogen receptor functionsNew stably transfected bioluminescent cells expressing FLAG epitope-tagged estrogen receptors to study their chromatin recruitment.Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulationHuman phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferationPhosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer.Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis.A dominant negative ERβ splice variant determines the effectiveness of early or late estrogen therapy after ovariectomy in ratsSelectively targeting estrogen receptors for cancer treatment.Estrogen signaling via estrogen receptor {beta}Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sitesInteractions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells.Tissue-Dependent Expression of Estrogen Receptor β in 17β-Estradiol-Mediated Attenuation of Autoimmune CNS Inflammation.AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancerMolecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.Estrogen receptor-beta and breast cancer: translating biology into clinical practiceOpposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR-218/PTPA pathwayEstrogen signaling and cardiovascular disease.Ligand Independent and Subtype-Selective Actions of Thyroid Hormone Receptors in Human Adipose Derived Stem Cells.Oestrogen receptors interact with the α-catalytic subunit of AMP-activated protein kinase.Estrogen receptor beta: an overview and updateEstradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis.The genome landscape of ERalpha- and ERbeta-binding DNA regions.Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiterDerailed estrogen signaling and breast cancer: an authentic couple.AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression.RING finger protein 31 promotes p53 degradation in breast cancer cells.Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging.Differential regulation of oestrogen receptor β isoforms by 5' untranslated regions in cancerFetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genesActivation of ERα signaling differentially modulates IFN-γ induced HLA-class II expression in breast cancer cells.SHARPIN Facilitates p53 Degradation in Breast Cancer Cells.Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer.Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells.Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers.
P2860
Q26773907-183598E7-E7F1-4C17-A2BD-EA6D8C7FB958Q28077543-986E92C6-8D73-4855-9893-B6504F488DDAQ28744012-6656DCD0-F407-478B-B64E-2D2FCCCC40ECQ33500874-A41F55F6-7E44-464A-A527-772810102E28Q33723377-C94FE431-FB78-447A-BCA5-A8BC338B02AAQ33793540-C6405476-5515-444D-871F-487CB50A31CCQ33991159-0E975034-B077-49E8-92BE-E43791F2CBA6Q34077212-DBB3677E-39E8-4B37-B242-2830C4CB206AQ34086835-DA91234C-D38E-4733-B86B-5D8923550D35Q34113589-D36A283A-A916-4D39-B8B0-324849EA7F3EQ34201028-F60D4815-50C5-4059-B262-CB58A1870B22Q34349374-D45596AD-4AC6-4141-BA32-388160F7FDF4Q34400742-F671DA6F-9389-40D2-9707-569A12021835Q34682354-38D8CC61-DAE8-446B-8230-BF2F8877D27BQ35622899-D524BD2A-45E7-4465-83D7-7CF1E6CCE4F5Q35661892-8AB320F9-1056-45B8-A0A6-8EB5427B699EQ35781425-04031DD7-D883-4639-A577-FF732C1F4502Q35796047-61F0A67A-9BD5-4020-BE6E-E43A20B6B8B1Q35973424-15743901-072E-4FF3-A67F-7F2046190052Q36057659-FFA81C80-4200-4C56-A56E-5A7F0E01401EQ36099354-6DFE3DF2-8688-4ED0-80A0-5525D260FBDAQ36161537-73E1D69F-E4D1-40C3-AB05-7821882B1683Q36227345-8BCC1256-AD6A-42DD-87AD-4C3E0654B554Q36478020-AC3CF956-CA34-46D0-8B0F-CC0EFC3F3F04Q36487632-BDE6CA44-57D0-4488-9511-4F9E96E50C23Q36497435-A386A8E3-283B-4EF8-BC4B-6B00AB5C48F2Q36577136-8542EE71-112B-4D72-B464-2FFB04BC8ACAQ36589361-B784A922-2055-4FAE-8F32-3260742BE734Q36650302-6F90CFC4-68AC-423E-A535-FAB455D42ACFQ36804413-BA2FB127-EB83-42D0-B4FC-BC3586A2D0F1Q36991794-B76F7308-BC00-4932-A51F-09B6CE314EA2Q37294996-50355407-1CF9-4819-A0F9-458DA3721D76Q37369129-209C4B28-8343-48E4-8B7F-15F9C8C5553CQ37521175-0D53102B-EAC6-4D86-926F-5EAA17CFE003Q37569188-E07A177A-3808-4DE7-A0F0-F35D48371FF3Q37571359-D39C766A-FC0E-4B01-B3BC-97E9D60F5CAEQ37687668-5DB14B88-72C9-4316-BCE5-B4107391FB3EQ37690691-782C9573-8293-48BD-A25F-034B216245D0Q38543678-929757B7-36D5-40B7-AD35-2BA56D5F9893Q38637559-9902734F-A175-4302-8333-F63CCBBAA868
P2860
Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Estrogen receptor beta2 negati ...... in human breast cancer cells.
@en
type
label
Estrogen receptor beta2 negati ...... in human breast cancer cells.
@en
prefLabel
Estrogen receptor beta2 negati ...... in human breast cancer cells.
@en
P2093
P50
P1433
P1476
Estrogen receptor beta2 negati ...... in human breast cancer cells.
@en
P2093
Anders Ström
Chunyan Zhao
Gudrun Toresson
Guojun Cheng
Jinghong Wan
Michel Tujague
P304
P356
10.1158/0008-5472.CAN-06-3505
P407
P577
2007-04-01T00:00:00Z